Skip to main content
RYTM logo

RYTM · Rhythm Pharmaceuticals, Inc.

Track RYTM — free
$115.48 -0.54 (-0.47%) At close · Aug 14
Market Cap
$7.95B
Shares
68.85M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
David Meeker $17,544,525
Hunter Smith $6,228,429
Yann Mazabraud $6,118,455
Jennifer Lee $5,602,816
Alastair Garfield $4,427,024
Fiscal 2024
Executive Total
David Meeker $14,663,742
Yann Mazabraud $5,095,270
Hunter Smith $5,050,410
Jennifer Lee $4,318,212
Fiscal 2023
Executive Total
David Meeker $7,230,457
Hunter Smith $2,308,007
Jennifer Lee $2,106,210
Yann Mazabraud $1,742,009
Joseph Shulman $1,740,468
Fiscal 2022
Executive Total
David Meeker $3,325,758
Hunter Smith $1,215,125
Yann Mazabraud $1,189,905
Jennifer Lee $1,086,675
Jennifer Chien $1,086,675
Joseph Shulman $950,113
Fiscal 2021
Executive Total
David Meeker $6,458,360
Hunter Smith $2,309,413
Yann Mazabraud $2,177,605
Jennifer Lee $2,081,453
Jennifer Chien $2,081,452
Murray Stewart $1,990,752
Joseph Shulman $1,788,243
Fiscal 2020
Executive Total
David Meeker $14,277,367
Keith M. Gottesdiener $3,449,169
Hunter Smith $2,662,468
Murray Stewart $2,300,314
Nithya Desikan $1,943,971
Jennifer Chien $1,819,617
Fiscal 2019
Executive Total
Keith M. Gottesdiener $4,937,042
Hunter Smith $1,922,853
Nithya Desikan $1,810,241
Fiscal 2018
Executive Total
Keith M. Gottesdiener $3,539,804
Hunter Smith $1,587,137

Executive changes

Person Change Filed
Edward T. Mathers Resigned 2026-04-03
Kimberly J. Popovits Appointed 2026-04-03
Camille L. Bedrosian, M.D. Resigned 2025-12-19
William T. Roberts Terminated 2023-08-08
Key facts CIK 1649904 CUSIP 76243J105 13F (30d) 283 filings 281 filers Visit website Investor relations